TAZOHEX 4.5gm

Description

TAZOHEX-4.5GM is a combination antibiotic injection containing Piperacillin Sodium and Tazobactam. Piperacillin belongs to the penicillin class of antibacterial medicines, while Tazobactam inhibits certain beta-lactamase enzymes that can reduce the activity of beta-lactam antibiotics. Together, the combination provides broad antibacterial coverage against susceptible bacteria.

The product information supplied with the pack lists Lower Respiratory Tract Infections, Urinary Tract Infections, Intraabdominal Infections and Skin & Tissue Infections among its benefits. However, doctors should select this antibiotic according to the suspected or confirmed bacterial infection, susceptibility results and the patient’s clinical condition.

For related pharmaceutical formulations and therapeutic segments, explore the Medhexa Pharma product range.

Therapeutic Segment

Antibiotics | Anti-Infectives | Hospital & Critical Care

Uses of TAZOHEX-4.5GM

TAZOHEX-4.5GM may help treat selected serious bacterial infections when a physician considers Piperacillin and Tazobactam appropriate.

The product information supplied with the pack lists:

• Lower Respiratory Tract Infections
• Urinary Tract Infections
• Intraabdominal Infections
• Skin & Tissue Infections

Official prescribing information supports Piperacillin and Tazobactam for selected intra-abdominal infections, pneumonia and skin and skin-structure infections. Healthcare professionals should confirm the bacterial cause and susceptibility whenever appropriate before selecting treatment.

Because antibiotic selection depends on the infection and the patient’s condition, the treating physician should decide whether this combination suits the individual case.

Key Benefits of TAZOHEX-4.5GM

• Combines Piperacillin, a penicillin-class antibacterial, with Tazobactam, a beta-lactamase inhibitor.
• Provides antibacterial coverage against susceptible organisms.
• May support treatment of selected serious bacterial infections.
• The supplied product information lists respiratory, urinary, intra-abdominal and skin/tissue infections among its clinical uses.
• Offers an injectable formulation for hospital and supervised clinical use.
• Supports targeted antibiotic therapy when the causative bacteria show appropriate susceptibility.

How TAZOHEX-4.5GM Works

TAZOHEX-4.5GM combines two components that work together against susceptible bacteria.

First, Piperacillin interferes with bacterial cell-wall synthesis. This action weakens the bacterial cell wall and can lead to bacterial death.

However, some bacteria produce enzymes called beta-lactamases that can break down certain beta-lactam antibiotics. Tazobactam inhibits several of these enzymes.

As a result, Tazobactam can protect Piperacillin from degradation by susceptible beta-lactamases and help maintain its antibacterial activity. Nevertheless, the combination does not overcome every resistance mechanism, so clinicians should consider local resistance patterns and microbiological results when appropriate.

Common Side Effects of TAZOHEX-4.5GM

Some patients may experience side effects during treatment, including:

• Diarrhea
• Nausea
• Vomiting
• Headache
• Constipation
• Injection-site reactions
• Skin rash

In addition, antibiotic treatment can sometimes cause serious hypersensitivity reactions or antibiotic-associated diarrhea.

Therefore, patients should promptly inform their healthcare professional if they develop severe or persistent diarrhea, extensive skin rash, breathing difficulty, facial swelling or other unusual symptoms.

Important Safety Information

Prescription and professional use: TAZOHEX-4.5GM should be used only under the direction and supervision of a qualified healthcare professional.

Penicillin allergy: Patients with a history of serious allergic reactions to penicillins, cephalosporins or other beta-lactam antibiotics require careful medical assessment before treatment. Piperacillin and Tazobactam can cause serious hypersensitivity reactions.

Antibiotic resistance: Use this medicine only when a bacterial infection is proven or strongly suspected. Unnecessary antibiotic use can contribute to antimicrobial resistance.

Kidney function: Piperacillin and Tazobactam dosing may require adjustment in patients with renal impairment. Therefore, the physician should assess kidney function when clinically appropriate.

Bleeding risk: Piperacillin and Tazobactam can affect coagulation parameters in some patients, particularly those with risk factors or certain underlying conditions. Doctors may monitor appropriate laboratory parameters when necessary.

Electrolytes: The formulation can contribute sodium to the patient’s overall intake. Patients with conditions requiring sodium restriction should discuss this with their healthcare professional.

Drug interactions: Patients should inform their doctor about all medicines they currently take. Important interactions can involve anticoagulants, methotrexate, vecuronium, probenecid and certain aminoglycosides.

Pregnancy and breastfeeding: Patients who are pregnant, planning pregnancy or breastfeeding should inform their healthcare professional before receiving this medicine.

Dosage & Administration

The dosage and duration of TAZOHEX-4.5GM depend on the type and severity of infection, the patient’s age and weight, kidney function, and the susceptibility of the suspected or confirmed bacteria.

A qualified healthcare professional should determine the dose and administration schedule. Do not self-administer this injection.

The product should undergo appropriate reconstitution and administration according to the manufacturer’s approved instructions. The healthcare professional should also inspect the prepared solution before administration.

For patients with reduced kidney function, the physician may adjust the dosage and dosing interval according to renal function.

Storage

• Store TAZOHEX-4.5GM according to the manufacturer’s labelled storage conditions.
• Protect the vial from unsuitable temperatures, moisture and direct light where applicable.
• Keep the medicine out of reach of children.
• Do not use the product after its expiry date.
• Do not use the vial if the container appears damaged or the powder shows an abnormal appearance.
• After reconstitution, follow the manufacturer’s instructions regarding preparation, storage and administration.